aldosterone has been researched along with olmesartan medoxomil in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichikawa, S; Takayama, Y | 1 |
Catanzaro, D; Laragh, JH; Resnick, LM; Sealey, JE | 1 |
Jones, MR; Laragh, JH; Sealey, JE | 1 |
Itabashi, M; Kojima, C; Moriyama, T; Nitta, K; Ogawa, T; Sugiura, H; Takei, T; Tsuchiya, K; Tsuruta, Y; Uchida, K | 1 |
Akizawa, T; Honda, H; Niikura, K; Suzuki, R | 1 |
Ahmad, S; Batlle, D; Brosnihan, KB; Ferrario, CM; Moniwa, N; Varagic, J; VonCannon, JL; Wysocki, J | 1 |
5 trial(s) available for aldosterone and olmesartan medoxomil
Article | Year |
---|---|
Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Pulse; Renin; Renin-Angiotensin System; Respiration Disorders; Tetrazoles; Time Factors | 2001 |
Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
Topics: Adult; Aldosterone; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biomarkers; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imidazoles; Male; Natriuresis; New York; Olmesartan Medoxomil; Predictive Value of Tests; Receptors, Angiotensin; Reference Values; Renin; Renin-Angiotensin System; Statistics as Topic; Tetrazoles; Time Factors; Treatment Outcome; Vascular Resistance; Vasoconstriction | 2004 |
Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Imidazoles; Irbesartan; Male; Middle Aged; Olmesartan Medoxomil; Prognosis; Radioimmunoassay; Reference Values; Renin; Renin-Angiotensin System; Single-Blind Method; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan | 2007 |
Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease.
Topics: Adult; Aldosterone; Amides; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Fumarates; Glomerular Filtration Rate; Humans; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Proteinuria; Renal Insufficiency, Chronic; Renin; Tetrazoles; Young Adult | 2012 |
Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Prospective Studies; Renal Dialysis; Renin; Tetrazoles | 2012 |
1 other study(ies) available for aldosterone and olmesartan medoxomil
Article | Year |
---|---|
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Tetrazoles | 2013 |